Cargando…
Translating Scientific Advances in the AOP Framework to Decision Making for Nanomaterials
Much of the current innovation in advanced materials is occurring at the nanoscale, specifically in manufactured nanomaterials (MNs). MNs display unique attributes and behaviors, and may be biologically and physically unique, making them valuable across a wide range of applications. However, as the...
Autores principales: | Ede, James D., Lobaskin, Vladimir, Vogel, Ulla, Lynch, Iseult, Halappanavar, Sabina, Doak, Shareen H., Roberts, Megan G., Shatkin, Jo Anne |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7353114/ https://www.ncbi.nlm.nih.gov/pubmed/32599945 http://dx.doi.org/10.3390/nano10061229 |
Ejemplares similares
-
The application of existing genotoxicity methodologies for grouping of nanomaterials: towards an integrated approach to testing and assessment
por: Verdon, Rachel, et al.
Publicado: (2022) -
Meta-analysis of transcriptomic responses as a means to identify pulmonary disease outcomes for engineered nanomaterials
por: Nikota, Jake, et al.
Publicado: (2016) -
Risk Analysis of Cellulose Nanomaterials by Inhalation: Current State of Science
por: Ede, James D., et al.
Publicado: (2019) -
In vitro micronucleus assay: Method for assessment of nanomaterials using cytochalasin B
por: Farabaugh, Christopher S., et al.
Publicado: (2023) -
Building a Network of Adverse Outcome Pathways (AOPs) Incorporating the Tau-Driven AOP Toward Memory Loss (AOP429)
por: Tsamou, Maria, et al.
Publicado: (2022)